PEAR
Pear Therapeutics, Inc. Class A Common Stock
PEAR
PEAR
Delisted
PEAR was delisted on the 18th of April, 2023.
49 hedge funds and large institutions have $385M invested in Pear Therapeutics, Inc. Class A Common Stock in 2022 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
Holders
49
Holders Change
+24
Holders Change %
+96%
% of All Funds
0.78%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
26
Increased
5
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$5.28M |
| 2 |
2
BlackRock
New York
|
$2.1M |
| 3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$1.44M |
| 4 |
HF
4
HRT Financial
New York
|
$761K |
| 5 |
ECM
5
ExodusPoint Capital Management
New York
|
$624K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
51
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
52
Citigroup
New York
| $0 | 50 | +50 | New |
|